- Home
- BHC vs EWTX Comparison
BHC vs EWTX Comparison
Compare BHC & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHC
- EWTX
- Stock Information
- Founded
- BHC N/A
- EWTX 2017
- Country
- BHC Canada
- EWTX United States
- Employees
- BHC N/A
- EWTX N/A
- Industry
- BHC Biotechnology: Pharmaceutical Preparations
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- BHC Health Care
- EWTX Health Care
- Exchange
- BHC Nasdaq
- EWTX Nasdaq
- Market Cap
- BHC 3.0B
- EWTX 2.7B
- IPO Year
- BHC N/A
- EWTX 2021
- Fundamental
- Price
- BHC $7.43
- EWTX $30.78
- Analyst Decision
- BHC Hold
- EWTX Buy
- Analyst Count
- BHC 4
- EWTX 6
- Target Price
- BHC $7.25
- EWTX $44.83
- AVG Volume (30 Days)
- BHC 1.4M
- EWTX 896.5K
- Earning Date
- BHC 10-30-2024
- EWTX 02-20-2025
- Dividend Yield
- BHC N/A
- EWTX N/A
- EPS Growth
- BHC N/A
- EWTX N/A
- EPS
- BHC N/A
- EWTX N/A
- Revenue
- BHC $9,474,000,000.00
- EWTX N/A
- Revenue This Year
- BHC $10.68
- EWTX N/A
- Revenue Next Year
- BHC $3.66
- EWTX N/A
- P/E Ratio
- BHC N/A
- EWTX N/A
- Revenue Growth
- BHC 10.91
- EWTX N/A
- 52 Week Low
- BHC $3.96
- EWTX $9.00
- 52 Week High
- BHC $11.46
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- BHC 37.99
- EWTX 48.57
- Support Level
- BHC $7.42
- EWTX $29.39
- Resistance Level
- BHC $7.79
- EWTX $35.50
- Average True Range (ATR)
- BHC 0.28
- EWTX 2.42
- MACD
- BHC -0.06
- EWTX 0.02
- Stochastic Oscillator
- BHC 8.40
- EWTX 44.47
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.